0 items

in your cart

  • Search for Medications
  • Viewcart | Checkout
  • Manage Account
  • Click-to-Call  

Prescription Drug Search

Strengths available for Naloxegol :

Naloxegol 12.5mg

Search for a drug:


Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about GlobalPharmacyMeds.to

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Naloxegol:

  • Anguilla
  • Argentina
  • Aruba
  • Australia
  • Azerbaijan
  • Bermuda
  • Brazil
  • China
  • Colombia
  • Cook Islands
  • Croatia
  • Cyprus
  • Czech Republic
  • European Union
  • Fiji
  • Gibraltar
  • Guadeloupe
  • Guam
  • Hungary
  • India
  • Iran
  • Iraq
  • Ireland
  • Korea, Republic of
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Netherlands Antilles
  • Nicaragua
  • Norway
  • Peru
  • Qatar
  • Saint Lucia
  • Slovenia
  • South Africa
  • Sri Lanka
  • United Kingdom, UK
  • United States, US
  • Uruguay
  • Vanuatu
View All Countries

Latest news releases on Naloxegol:

Naloxegol - Wikipedia

Naloxegol (INN; PEGylated naloxol; trade names Movantik and Moventig) is a peripherally selective opioid antagonist developed by AstraZeneca, licensed from Nektar Therapeutics, for the treatment of opioid-induced constipation. It was approved in 2014 in adult patients with chronic, non-cancer pain. Doses of 25 mg were found safe and well ...

MOVANTIK® (naloxegol) | Opioid Induced Constipation Treatment

Official Web site for MOVANTIK® (naloxegol) tablets, for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain.

Naloxegol for Opioid-Induced Constipation in Patients with ...

Background Opioid-induced constipation is common and debilitating. We investigated the efficacy and safety of naloxegol, an oral, peripherally acting, μ-opioid receptor antagonist, for the treatment of opioid-induced constipation. Methods In two identical phase 3, double-blind studies (study 04, 652 participants; study 05, 700 participants ...

Resultat - FASS Allmänhet

FASS.se - läkemedelsinformation för vårdpersonal, patienter och veterinärer

Naloxegol: un antagoniste opioïde pour vaincre la ...

Commentaire. A la lecture de cet article, le naloxegol semble être un traitement adéquat pour le traitement de la constipation induite par les opiacés.

Moventig 12.5 mg and 25mg tablets - Summary of Product ...

Moventig 12.5 mg film-coated tablets. Each film-coated tablet contains naloxegol oxalate equivalent to 12.5 mg naloxegol. Moventig 25 mg film-coated tablets


MOVANTIK® (naloxegol) tablets, for oral use 2.3 Dosage in Adult Patients with Renal Impairment The starting dosage for patients with creatinine clearance (CLcr) < 60 mL/min (i.e., patients with

N - na index - Drugs.com

Browse drugs and medications alphabetically. Includes N Ice, N Ice with Vitamin C, Na-Zone, Nabi-HB, Nabi-HB NovaPlus

Moventig - FASS Allmänhet

Moventig innehåller den aktiva substansen naloxegol. Det är ett läkemedel som används till vuxna för att behandla förstoppning orsakad av smärtlindrande läkemedel, så kallade opioid er (t.ex. morfin, oxikodon, fentanyl, tramadol och kodein), som tas regelbundet.


ASTRAZENECA PHARMACEUTICALS Patient Assistance Program. Patient assistance programs (PAPs) are programs created by drug companies, such as ASTRAZENECA PHARMACEUTICALS, to offer free or low cost drugs to individuals who are unable to pay for their medication.

Customer Service
1-866-799-3435 (Use ref# 10786) | Contact Form
Copyright © 2018 GlobalPharmacyMeds.to All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK